user

YIRUI Pharmaceutical Technology

Pharmaceutical Manufacturing

View the employees at

YIRUI Pharmaceutical Technology
  • image
    Xuefei zhou Medical and biotechnological expert in small molecular drugs, biological drugs research and development and leader of international business development and cooperation
    • Hangzhou, Zhejiang, China
    • Top 5%
    View Details
  • image
    Ying-Ying Li, Ph.D. VP of Pharmacology and Translational Medicine at Yirui Pharmaceuticals
    • Miami-Fort Lauderdale Area
    • Top 5%
    View Details

Overview

At YIRUI Pharmaceutical Technology, we are committed to providing innovative therapeutic solutions, which are anticipated to improve health of patients with serious disease and fill the urgent unmet medical needs. YIRUI Pharmaceutical Technology was founded in June 2018. We are currently in a period of rapid growth. With an extraordinarily talented team consisting of experienced pharmaceutical scientists, physicians and executives, we have identified and optimized a number of lead compounds against the first-in-class targets, which show high therapeutic potential for the treatment and prevention of chronic skin diseases, autoimmune disorders, diabetes complications and other serious diseases. By focusing on small molecule drugs development and patient-centered research, our perspective is to bring more and more safe, effective and affordable drugs with high quality to the largest number of patients.